iShares Core S&P 500 ETF vs MiniMed Group Inc. Common Stock — how do they compare? iShares Core S&P 500 ETF trades at $779.22 (market cap $897.20B), while MiniMed Group Inc. Common Stock trades at $19.57 (market cap $5.57B). The key difference: iShares Core S&P 500 ETF is far larger — about 161.1× MiniMed Group Inc. Common Stock's market cap, and iShares Core S&P 500 ETF is trading nearer its 52-week high, MiniMed Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Core S&P 500 ETF for 46 Days and MiniMed Group Inc. Common Stock for 0 Days on average.
| IVV | MMED | |
|---|---|---|
Market Cap | $897.20B | $5.57B |
Volume | 4,580,672 | 23,336,073 |
Sector | Broad Market / Factor | Health |
52-Week High | $782.58 | $23.84 |
52-Week Low | $634.93 | $10.80 |
Typical Hold Time | 46 Days | 0 Days |
Enterprise Value | — | $5.37B |
Signals from Pluang's Aura AI — not financial advice
IVV, tracking the S&P 500, trades at $780.6, down 0.25% on the day. Technical indicators show a bullish trend with strong moving average support, though RSI suggests potential overbought conditions near-term. The ETF benefits from diversified exposure to large-cap US equities, with recent news highlighting strong corporate earnings growth expectations of 35% for 2026. Market sentiment remains mixed amid concerns about valuation and profit growth normalization.
Outlook remains cautiously optimistic given the S&P 500's historical bullish seasonal patterns and strong institutional support. Key risks include elevated Treasury yields, concentration in top holdings, and potential earnings growth deceleration to 15% in 2027. The ETF's low-cost structure and broad market exposure provide defensive characteristics during market volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.
Read more on IVV →MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →